Tablet (Sublingual Transmucosal Disc) · Buprenorphine
Zentraxyl
Buprenorphine in a sublingual transmucosal tablet (200 mcg). High-precision partial opioid receptor modulation that relieves physical strain, dampens stress exhaustion, and cushions post-stimulant burnout without causing mental numbness.
- 200 mcg
- Sublingual transmucosal microdose.
- 6-8 h
- Smooth physical relief and emotional resilience.
- Clear
- Stress buffering and recovery without emotional flatlining.
Action & Kinetics
Zentraxyl binds with sub-nanomolar affinity to mu-opioid and delta-opioid receptors with partial agonist activity, while acting as an antagonist at kappa-opioid receptors. This specific configuration relieves somatic discomfort, buffers dynorphin-mediated stress circuits, and softens the end-of-day crash from intensive mental exertion without producing euphoria, sedation, or emotional detachment.
- Active MoleculeBuprenorphine
- Delivery SystemTablet (Sublingual Transmucosal Disc)
- Nominal Payload200 mcg
- Therapeutic Timing15 to 30 minute onset, 6 to 8 hour duration
Primary Clinical Effects
- Somatic Physical ReliefRelieves physical tension, neck and shoulder tightness, and somatic discomfort accumulated over long desk sessions.
- Porous Stress BufferingMuffles acute emotional exhaustion and reactivity without flattening normal mood or feeling emotionally numb.
- Post-Work Recovery LandingSmooths out late-day post-stimulant fatigue, enabling a restful evening transition with clear analytical lucidity.
Secondary Reactions & Cautions
The following physiological responses are documented during active administration:
- Mild Sedation & MiosisGentle relaxation and slight pupil constriction; does not impair clear thinking.
- Sublingual RequirementMust be absorbed under the tongue; swallowing destroys bioavailability due to complete first-pass liver metabolism.
- Opioid IncompatibilityStrictly contraindicated with full opioid analgesics; will precipitate severe withdrawal if taken concurrently.
Administration Protocol: Place tablet under the tongue and allow to dissolve completely over 5 to 10 minutes without swallowing, chewing, or drinking liquids during dissolution.
Testing & Sampling Status
Notice: This stuff is real, not fake, and we are currently in the active testing and sampling phase.
All formulations are synthesized and prepared under strict laboratory conditions in Perth, Western Australia. Inquiries for testing dossiers, institutional sampling batches, and analytical specifications should be directed to the engineering team.
Contact hello@caissonai.co or human@caissonai.co for sampling inquiries.